MIRM analyst estimates
Mirum Pharmaceuticals (MIRM) analyst ratings, the average price target and its range, and every firm's latest call.
MIRM analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 14, 2026 | Stifel Nicolaus | Mirum Pharmaceuticals price target raised to $156 from $136 at Stifel | $156.00 |
| Oct 13, 2026 | Evercore ISI | Mirum Pharmaceuticals price target raised to $146 from $135 at Evercore ISI | $146.00 |
| Oct 12, 2026 | H.C. Wainwright | Mirum Pharmaceuticals price target raised to $200 from $195 at H.C. Wainwright | $200.00 |
| Oct 12, 2026 | Morgan Stanley | Mirum Pharmaceuticals price target raised to $152 from $137 at Morgan Stanley | $152.00 |
| Oct 8, 2026 | RBC Capital | Mirum Pharmaceuticals price target raised to $155 from $135 at RBC Capital | $155.00 |
| Sep 29, 2026 | Robert W. Baird | Mirum Pharmaceuticals price target raised to $130 from $123 at Baird | $130.00 |
| Sep 28, 2026 | H.C. Wainwright | Mirum Pharmaceuticals price target raised to $195 from $140 at H.C. Wainwright | $195.00 |
| Sep 28, 2026 | Morgan Stanley | Mirum Pharmaceuticals (MIRM) PT Raised to $144 at Citizens | $144.00 |
| Aug 27, 2026 | UBS | Mirum Pharmaceuticals (MIRM) Reiterated at Market Outperform by Citizens | $137.00 |
| Aug 6, 2026 | H.C. Wainwright | Mirum Pharmaceuticals price target lowered to $140 from $185 at H.C. Wainwright | $140.00 |
| Aug 6, 2026 | RBC Capital | Mirum Pharmaceuticals price target lowered to $135 from $148 at RBC Capital | $135.00 |
| Aug 6, 2026 | Morgan Stanley | Mirum Pharmaceuticals price target lowered to $137 from $150 at Morgan Stanley | $137.00 |
| Aug 6, 2026 | Robert W. Baird | Mirum Pharmaceuticals price target lowered to $123 from $129 at Baird | $123.00 |
| Jul 7, 2026 | RBC Capital | Mirum Pharmaceuticals price target raised to $148 from $142 at RBC Capital | $148.00 |
| Jun 15, 2026 | CLSA | Mirum Pharmaceuticals (MIRM) PT Raised to $146 at Citizens After ENDO Data Reveal | $146.00 |
- 13 firms rate MIRM: 13 buy, 0 hold, 0 sell.
- The average price target is $152.75 from 8 analysts, from $130.00 to $200.00.
Updated 2026-11-03 00:00 UTC